Collegium Pharmaceutical Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
United States of America US
Employees
423
IPO date
May 7, 2015

Collegium Pharmaceutical makes prescription medicines for pain management and related conditions. Its main product portfolio centers on branded therapies that doctors prescribe to patients who need longer-lasting pain control, especially in settings where other treatments have not worked well or are not appropriate. The company focuses on a narrow set of medicines rather than a broad drug catalog.

It sells these drugs mainly to pharmacies, distributors, and other healthcare channels that reach patients through doctors and insurers. Collegium makes money by selling its branded prescriptions and by supporting access through payer coverage, pharmacy distribution, and patient programs. In practice, its business depends on how well its medicines are adopted by prescribers and covered by health plans.

What makes Collegium different is that it is a focused specialty pharmaceutical company built around pain products, where treatment choices, safety concerns, and prescribing rules matter a lot. That gives it a role in the drug value chain as a marketer and manager of branded medicines rather than a research-heavy broad pharma company or a generic drug maker.

Collegium Pharmaceutical Inc Investor Relations

Address
100 Technology Center Dr
Stoughton, Massachusetts
United States of America

Business Segments

Pain medicines

Collegium develops and markets prescription medicines for managing chronic and severe pain, including branded products such as Xtampza ER and Belbuca. It focuses on medicines that doctors prescribe when standard pain tre...

Customers and revenue model

Management

Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.

Co-Founder & Chairman

Biography unavailable

Ms. Colleen Tupper

Executive VP & CFO

Biography unavailable

Ms. Shirley R. Kuhlmann J.D.

Executive VP, General Counsel, Chief Administrative Officer & Secretary

Biography unavailable

Mr. Scott Dreyer

Executive VP & Chief Commercial Officer

Biography unavailable

Dr. Thomas B. Smith FAAFP, M.D.

Executive VP & Chief Medical Officer

Biography unavailable

Mr. Vikram Karnani

CEO, President & Director

Biography unavailable

Dr. Christopher Shayne James M.D.

Vice President of Investor Relations

Biography unavailable

Mr. Bart J. Dunn

Executive Vice President of Strategy & Corporate Development

Biography unavailable

Mr. Scott Sudduth

Head of Technical Operations

Biography unavailable

1 / 9